Search

You searched for "Laser"

4138 results found

A standardised strategy for uveitis etiological diagnosis

1 August 2017 | | Retina / Uvea / Vitreous
This was a prospective, non-inferiority, multicentre randomised control trial, which aimed to assess the effectiveness of a standardised approach in the etiological diagnosis of uveitis versus an open strategy, where clinicians could perform any test. The authors developed their standardised...

Intravitreal afibercept and ranibizumab for PCV

1 August 2016 | | Retina / Uvea / Vitreous
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...

What effects do repeated Ozurdex implants have in paediatric uveitis?

1 April 2016 | | Paediatric Ophthalmology / Strabismus
The aim of this retrospective study was to assess the anatomical and functional results, as well as complications of repeated Ozurdex intravitreal implants in a paediatric (non-infectious) uveitis cohort. Twenty-two eyes (16 patients) received 35 Ozurdex implants over a six...

Stereotactic radiotherapy for polypoidal choroidal vasculopathy

1 August 2015 | | Retina / Uvea / Vitreous
Polypoidal choroidal vasculopathy (PCV) is a variant of neovascular AMD. It is a disease of choroidal vasculature characterised by abnormal branching vascular network with aneurysmal dilatations (polyps). Features of PCV include pigment epithelial detachments (PED), subretinal fluid (SRF) accumulation and...

Ophthalmic history made easy

13 March 2019
There are now three ophthalmic medical documentaries to dip into on to Royal College of Ophthalmologists website.

Viral conjunctivitis and COVID-19

23 March 2020 | COVID-19
A joint statement was released by the Royal College of Ophthalmologists and College of Optometrists on 19 March.

Optical practices in England need "financial lifeline"

30 March 2020 | COVID-19
NHS England’s failure to act is forcing hundreds of optical practices to close, with a direct and dangerous impact on the eye healthcare of patients in England during the COVID-19 crisis, the Optical Fees Negotiating Committee (OFNC) has warned.

Johnson & Johnson announces lead vaccine candidate for COVID-19

30 March 2020 | COVID-19
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate and the rapid scaling of its manufacturing capacity with the goal of providing global supply of more than one billion doses.

World Ophthalmology Congress goes virtual

2 April 2020 | COVID-19
The World Ophthalmology Congress (WOC2020) has decided to make its June meeting virtual, to provide "an opportunity to come together, collaborate and share the latest advancements in eye care".

COVID-19 elective oculoplastic consent proforma

1 July 2020 | COVID-19
The advent of COVID-19 will continue to impose major adaptations in how we as surgeons practise and offer elective surgery going forward. In addition to how we try to adapt to make our practice as safe for the patient and our teams as...

British Council for Prevention of Blindness has a new Chairman

9 November 2020
BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.

OSA Sustainability Committee holds first meeting

4 August 2021
The OSA Sustainability Committee held its first meeting on Friday 23 July. The aim of the committee is to provide information, support and advice to OSA members who want to demonstrate their commitment to behaving in a more environmentally sensitive and more sustainable way.